Skip to content

US · GRX · ASSET MANAGEMENT

The Gabelli Healthcare & Wellness Trust (GRX) intrinsic value and stock valuation

$9.96as of 2026-11-21 · Mkt cap 144.02M

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

The Gabelli Healthcare & Wellness Trust DCF and intrinsic value

InvestorsCraft values GRX with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from GRX’s statements →

The Gabelli Healthcare & Wellness Trust Graham Number

Graham Number: $5.91d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Financial Services · Asset Management Rye, NY 10580-1422 gabelli.com

How the business is doing

Fiscal 2017–2025, USD

Revenue
$15.3M-9.4% 5y CAGRd
20172025
Net income
$2.29M-37.6% 5y CAGRd
20172025
Free cash flow
$9.43M-26.9% 5y CAGRd
20192025
Total equity
$158.5M-8.1% 5y CAGRd
20172025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2017–2025, USD
20252024202320222021
Revenue$15.3M$3.26M$4.01M$15.6M$23.4M
Operating income$4.74M$2.68M$3.2M-$-44.26M$44.7M
Net income$2.29M-$-280K$420K-$-47.44M$42.7M
EPSd$149.7K-$-18.04K$26.3K-$-2.78M$2.48M
Operating cash flow$9.43M$13.1M-$-360K$58.1M-$-18.94M
Capital expenditure$0.00-$0.00-$0.00$0.00$0.00
Free cash flow$9.43M$13.1M-$-360K$58.1M-$-18.94M
Total assets$241.9M$225.7M$239M$248.7M$350.8M
Total debt$70.7M$10K$53.3M$40M$70K
Net debt$70.7M$10K$53.3M$40M$70K
Total equity$158.5M$170.9M$184.8M$204.7M$264M
Cash and short-term investments$20K$0.00$0.00$50K$0.00
Income statement
20252024202320222021
Revenue$15.3M$3.26M$4.01M$15.6M$23.4M
Cost of revenue$2.48M$2.92M$2.77M$3.41M$3.46M
Gross profit$12.8M$340K$1.24M$12.2M$19.9M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$0.00$420K$540K$730K$750K
Other expenses$8.05M$210K$270K-$0.00-$0.00
Operating expenses$8.05M$630K$820K$730K$750K
Cost and expenses$10.5M$3.54M$3.59M$59.8M-$-21.3M
Interest income$3.7M$380K$640K$460K$10K
Interest expense$2.47M$2.92M$2.77M$3.18M$1.94M
Depreciation and amortization$0.00$0.00$0.00$230K$240K
Ebitda$4.77M$2.68M$3.2M-$-44.26M$44.9M
Operating income$4.74M$2.68M$3.2M-$-44.26M$44.7M
Total other income/expenses, net-$-2.45M-$-2.97M-$-2.78M-$-3.21M-$-1.95M
Income before tax$2.29M-$-280K$420K-$-47.44M$42.7M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income$2.29M-$-280K$420K-$-47.44M$42.7M
Weighted average shares outstanding$15.3M$15.5M$16M$17M$17.2M
Weighted average diluted shares outstanding$15.3M$15.5M$16M$17M$17.2M
Balance sheet
20252024202320222021
Cash and short-term investments$20K$0.00$0.00$50K$0.00
Net receivables$390K$420K$770K$6.63M$480K
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$410K$430K$780K$6.68M$480K
Property, plant and equipment, net$0.00$0.00$0.00$0.00$0.00
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$241.2M$225M$238.1M$241.9M$350.2M
Total non-current assets$241.5M$225.3M$238.3M$241.9M$350.2M
Total assets$241.9M$225.7M$239M$248.7M$350.8M
Accounts payable$12M$180K$30K$3.53M$6.23M
Short-term debt$0.00$0.00$0.00$0.00$70K
Deferred revenue$0.00$0.00-$-30K$0.00$6.16M
Total current liabilities$12.5M$180K$0.00$3.53M$6.23M
Long-term debt$70.7M$10K$0.00$0.00$70K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$83.4M$54.7M$54.2M$40.5M$70K
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$83.4M$54.9M$54.2M$44M$86.9M
Common stock$105.5M$110M$114.3M$125.1M$126.8M
Retained earnings$53M$60.9M$70.5M$79.6M$137.1M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$158.5M$170.9M$184.8M$204.7M$264M
Total investments$241.2M$225M$238.1M$241.9M$350.2M
Total debt$70.7M$10K$53.3M$40M$70K
Net debt$70.7M$10K$53.3M$40M$70K
Cash flow statement
20252024202320222021
Net income$2.29M-$-280K$420K-$-47.44M$42.7M
Depreciation and amortization$0.00$0.00$0.00$0.00$0.00
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital$11.8M$250K$2.43M-$-2.8M$7.23M
Accounts receivable$30K$350K$5.85M-$-6.15M$4.63M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$11.9M$140K-$-3.48M$3.41M-$-3.46M
Net cash provided by operating activities$9.43M-$-2.33M-$-360K$58.1M-$-18.94M
Investments in property, plant and equipment$0.00$0.00-$0.00$0.00$0.00
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$67.6M$18.3M-$-70K$48M-$-4.85M
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased-$-4.37M-$-4.47M-$-9.94M-$-41.6M-$-4.41M
Dividends paid-$-10.15M-$-9.37M-$-9.94M-$-16.47M-$-16.52M
Net cash used for financing activities$2.11M-$-13.11M-$-6.66M-$-58.06M$18.9M
Net change in cash$20K-$0.00-$-50K$50K-$-10K
Cash at end of period$20K$0.00$0.00$50K$22.7M
Operating cash flow$9.43M$13.1M-$-360K$58.1M-$-18.94M
Capital expenditure$0.00-$0.00-$0.00$0.00$0.00
Free cash flow$9.43M$13.1M-$-360K$58.1M-$-18.94M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About The Gabelli Healthcare & Wellness Trust

        The Gabelli Healthcare & Wellness Trust operates as a closed-ended equity fund, originally established by GAMCO Investors, Inc. Gabelli Funds, LLC serves as its investment manager. This fund's mandate is to invest globally in public equities, with a predominant focus on companies operating within the healthcare and wellness sectors. It considers businesses irrespective of their market capitalization, investing across the full spectrum. To gauge its performance, the Trust benchmarks its portfolio against the S&P 500 Index, the S&P 500 Consumer Staples Index, and the S&P 500 Health Care Index. Formed on February 20, 2007, The Gabelli Healthcare & Wellness Trust is domiciled in the United States.

        CEO
        Wayne Christopher Pinsent
        Employees
        0
        Beta
        0.82

        Explore

        Frequently asked questions

        What is the intrinsic value of The Gabelli Healthcare & Wellness Trust (GRX)?

        The Gabelli Healthcare & Wellness Trust (GRX) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is GRX undervalued?

        GRX trades at a price of $9.96 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.